Taiwan scientists synthesize more than 1 gram of Remdesivir

Taiwan scientists synthesize more than 1 gram of Remdesivir

National Health Research Institutes scientists say they’ve been able to synthesize more than 1 gram of Remdesivir, an experimental drug that’s shown promise in treating COVID-19. The drug was first developed and patented by U.S. pharmaceutical Gilead Sciences. Taiwan’s government is reportedly in talks with Gilead over rights to mass-produce a generic version of Remdesivir to fight the epidemic. The researcher raises a round-bottom flask and mixes its contents, before inspecting the state of the drug. In a complex lab procedure, Taiwan scientists have been able to replicate Remdesivir, an antiviral drug with the potential to treat COVID-19.Chen Chiung-tongNational Health Research Institutes We’ve synthesized the drug at the gram level. That is 1,000 times more than the milligram-level production that was reported last week. This drug was in fact used in clinical trials for Ebola patients. In the U.S., it’s had positive effects on the treatment of COVID-19 patients in the state of Washington. So although it’s not on the market, we’re willing to give it a try.Researchers confirmed the good news. Working around the clock for five days, experts at the National Health Research Institutes were able to achieve breakthroughs in Remdesivir production. Amid its outbreak, China has begun a Phase III clinical trial of Remdesivir. Meanwhile, Taiwan has worked on replicating the drug from scratch. Last week, Academia Sinica managed to produce the drug at the milligram level with 97% purity. This week, National Health Research Institutes reached the gram milestone twice as fast as expected.Chen Chiung-tongNational Health Research Institutes The active ingredient we produce could really become a drug to treat patients on a large scale. So for mass production, we’re talking about 1,000 times more artificial crystals. In addition, our vaccinology institute is working very hard to develop a vaccine.The National Health Research Institutes says it’s seeking corporate partners to launch the drug into test production at the 100-gram or kilogram level. Scientists say that with more work and testing, there could be a ray of hope on the deadly outbreak.
cached video